WHWK
Whitehawk Therapeutics, Inc.
3.90$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.2% | -15.4% | +15.4% | +16.7% | +0.4% | -1.3% | -100.0% | – | – | – | – | – | |
| – | +8.8% | +4.0% | -2.6% | -22.1% | +40.1% | -95.0% | -97.9% | -68.8% | -80.0% | -100.0% | – | – | |
| – | – | – | – | – | – | – | -100.3% | – | – | – | – | – | |
| – | +7.4% | +6.5% | -3.7% | -23.6% | +43.5% | -38.7% | +455.4% | -70.6% | +32.6% | -9.4% | -25.2% | – | |
| – | -7.8% | +2.7% | -25.7% | -8.9% | +53.8% | +16.0% | -53.6% | -12.4% | +12.8% | +7.2% | -17.1% | – | |
| – | -7.8% | +2.7% | -25.7% | +24.5% | +12.5% | +95.5% | +153.4% | -64.3% | +27.4% | -5.5% | -23.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.7% | +1.8% | +0.0% | -34.5% | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -172.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | -172.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | -172.0% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.